CETIRIZINE, 10mg, tab.
NST
DORACETI1T-
Valid Article
HS Code:
300490
Last Updated on:
23/11/2024, 00:00:10
Former
Code(s):
DORAZBD0421 DORAZRU0047 DORACETI2T-
3 - Antiallergics and medicines used in anaphylaxis
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
R06AE07
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
CETIRIZINE - NST
Please always consider the MSF STD (loratadine) before ordering a NST.
- Not in the WHO list of Essential Medicines 2023 Therapeutic alternative to loratadine
Therapeutic Action
Antihistamine for systemic use, piperazine derivatives.
Potent and selective antagonist of peripheral histamine H1-receptors.
Indications
Symptomatic treatment of minor allergic reactions (urticaria, allergic conjunctivitis, etc.) in adults and children aged 2 years and above.
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
The recommended initial dose is 5 to 10 mg, depending on symptom severity, given as a single daily dose.
Loratadine is preferred to cetirizine because it causes less side effects like sleepiness.
Precautions for Use
Do not administer in children below 2 years of age.
May cause sleepiness, fatigue, nausea or headache.
Storage
Below 25ºC
Description updated and validated by Spinco on 04/09/2023.
![[DORALORA1T-] LORATADINE, 10mg, tab.](/web/image/product.template/573292/image_256/%5BDORALORA1T-%5D%20LORATADINE%2C%2010mg%2C%20tab.?unique=16056c6)